JPRN-UMIN000007456已完成未知
Mechanisms of antiproteinuric effects of azelnidipine in hypertensive patients with type 2 diabetes mellitus - Mechanisms of antiproteinuric effects of AzelnidiPine IN hypertensive patients with type 2 Diabetes Mellitus (MAP in DM)
Komono Kosei Hospital0 个研究点目标入组 30 人开始时间: 2012年3月8日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Exclusion criteria are: secondary hypertension; history of acute coronary syndrome, heart failure, coronary revascularization, or stroke within the previous 6 months; uncontrolled diabetes mellitus (HbA1c >9.0%); confirmed or suspected renal artery stenosis; serum creatinine of 1.5mg/dl or more for men and 1.2mg/dl or more for women; contraindication to calcium channel blockers; pregnant women; or clinic systolic blood pressure >180mmHg and/or diastolic blood pressure >110mmHg.
研究者
相似试验
已完成
不适用
Inhibitory effect of azelnidipine on sympathetic nerve activity in hypertensive patients Evaluation of different class effect of calcium channel blocker by using muscle sympathetic nerve activityPrimary HypertensionJPRN-UMIN000009123Internal Medicine, Kanazawa University Hospital Disease Control and Homeostasis20
已完成
不适用
Comparison of effects of cilnidipine and azelnidipine on blood pressure and urinary albumin excretion in type 2 diabetics with hypertensioType 2 diabetic patientsJPRN-UMIN000007201Juntendo University Graduate School of Medicine20
已完成
2 期
Effect of pentoxifylline on urinary protein excretion reduction in diabetic nephropathy patients.Condition 1: Non-insulin-dependent diabetes mellitust. Condition 2: Diabetic Nephropathy.Non-insulin-dependent diabetes mellitusGlomerular disorders in diabetes mellitusIRCT138901013596N1research deputy of Ahvaz Jundishapur University100
已完成
4 期
antiproteinuric and antiinflammatory effect of vitamin D comparing with direct renin inhibitor in DKDAge > 18DKD with eGFR > 15 ml/min Optimal dose of ACEI or ARB 𕟵 monthsStable BP control ( ΔSBP 󖼚% )Stable renal function ( ΔeGFR 󖼚% )Stable glycemic cvitamin D ,Direct renin inhibitor ,diabetic kidney diseaseTCTR20120000008avamindhradhiraj university39
已完成
不适用
comparison of two drugs which lowers proteinuria in diabetic kidney diseaseCTRI/2012/04/002550Sowmya Bondalapati100